finance
How 2026 Regulatory Overhauls Could Rewrite the Biotech Stock Landscape: An Insider’s Forecast
How 2026 Regulatory Overhauls Could Rewrite the Biotech Stock Landscape: An Insider’s Forecast When the FDA announces its most sweeping reforms in decades, the biotech sector instantly shifts gears. The core question is: will these changes lift or flatten the market? In short, the answer is a nuanced “yes”